Skip to main content

Tweets

"Let the young know they will never find a more interesting, more instructive book than the patient himself." – Giorgio Baglivi

Dr. John Cush @RheumNow ( View Tweet )

5 months 3 weeks ago
Practical management of rheumatic immune-related adverse events with immune checkpoint inhibitors Joint Bone Spine has published a full read review of the management of immune-related adverse events (irAEs) in patients receiving Immune checkpoint inhibitors (ICIs) for cancer. https://t.co/i3FMOCbyNg
Dr. John Cush @RheumNow ( View Tweet )
5 months 3 weeks ago
If severe refractory SLE is defined as SLEDAI-2K≥10 despite steroids & immunosuppressives; Cohort of 3,744 SLE - 14% (578) had srSLE. Median SLEDAI-2K = 12, & decreased to 6 at 6m & 12m> < 25% achieved LLDAS & only 1% attained GC-free remission @ 12 mos https://t.co/7tehA27gyT https://t.co/yef4wCpqNf
Dr. John Cush @RheumNow ( View Tweet )
5 months 3 weeks ago
Emapalumab Approved for MAS in Still’s On June 27th, 2025, the FDA approved emapalumab for macrophage activation syndrome (MAS) in known or suspected Still’s disease (including both adult-onset Still’s disease (AOSD) and systemic juvenile idiopathic arthritis (sJIA)) with https://t.co/431PQlzBsV
Dr. John Cush @RheumNow ( View Tweet )
5 months 4 weeks ago
TNFi are relatively contraindicated in RA pts w/ #MS. Literature review suggests for pts w/ MS and RA, teriflunomide and anti-CD20 therapies are the most suitable, and Cladribine may also be considered https://t.co/gIVaJ7Kwn0 https://t.co/1ar0q2OnzB
Dr. John Cush @RheumNow ( View Tweet )
5 months 4 weeks ago
Fibrosis in IgG4-related disease due to the overexpression of early growth response-1 (EGR-1) by Epithelial cells that facilitates tissue fibrosis https://t.co/AEaoucfT13 https://t.co/7UVQpkj3cn https://t.co/PuCjh5LQc5
Dr. John Cush @RheumNow ( View Tweet )
5 months 4 weeks ago
NEJM images: 55-year-old man with metastatic squamous-cell lung cancer Hx& 6-wk Hx firm, painful swelling RToe1 & RDIP3 w/ ulceration. Xray showed lytic lesions due to acrometastases - rare bony metastases distal to elbow or knee, that may may mimic gout or osteomyelitis https://t.co/1Fh1Cp9dm9
Dr. John Cush @RheumNow ( View Tweet )
5 months 4 weeks ago
Have a rheumatology question or case for Dr.Cush? Record it here and we may feature it on an upcoming podcast https://t.co/B8lFlTwj10

Dr. John Cush @RheumNow ( View Tweet )

5 months 4 weeks ago
Survival in #RA pts undergoing cervical spine surgery is not good! Retrospective study of 139 RA pts who underwent Cx surgery shows higher mortality risk if they are older, w low albumin levels, high-dose pred. and have subaxial subluxation. https://t.co/hKvgaas2gh https://t.co/ygtJjb4mVl
Dr. John Cush @RheumNow ( View Tweet )
5 months 4 weeks ago
Subclinical Synovitis Among Psoriasis Patients A systematic review shows that imaging can be used to detect subclinical synovitis among patients with psoriasis and may identify individuals at risk for future psoriatic arthritis. https://t.co/2603Aax8PP https://t.co/2XDtDg1QHh
Dr. John Cush @RheumNow ( View Tweet )
5 months 4 weeks ago
New CDC report confirms a record number of Measles cases in the USA, now at 1,319 (in 39 states), the highest since 1992. National cases are more than 4.5 times higher than the entirety of last year, which had an estimated 285 cases reported. https://t.co/KkqQu9C4cO https://t.co/bND6hPDUNA
Dr. John Cush @RheumNow ( View Tweet )
5 months 4 weeks ago
Clinical Associations with Anti-RNA Polymerase III Antibodies A systematic review of anti-RNA polymerase III antibodies (ARA) in systemic sclerosis (SSc) patients finds ARA positivity in only 9% of SSc patients, but come with a higher risk of many potentially worrisome https://t.co/p1KVUFPJvN
Dr. John Cush @RheumNow ( View Tweet )
5 months 4 weeks ago
×